Effect of Vitamin D Status on Clinical Pregnancy Rates Following Intra Cytoplasmic Sperm Injection
1 other identifier
observational
240
1 country
1
Brief Summary
All patients will undergo in vitro fertilization. Serum 25 (OH) D samples will be collected within1 week before oocyte retrieval. Whole blood specimens will be collected in serum separator tubes using acceptable medical techniques to avoid hemolysis. Ultrasound guided fresh embryo transfer will be performed on day 5 after fertilization. clinical pregnancy will be confirmed by observation of intrauterine sac visible on ultrasound performed 4-5 weeks after embryo transfer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 29, 2016
CompletedFirst Posted
Study publicly available on registry
December 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 9, 2016
December 1, 2016
1 year
November 29, 2016
December 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pregnancy
4-5 weeks
Eligibility Criteria
* Age between 20 and 35 years old. * Body mass index between 20 - 30. * Unexplained infertility . * Follicle-stimulating hormone level 12 IU/L or lower (baseline level, cycle day 3). * Normal hysteroscopy . * Fresh embryo transfer of 2 or more blastocysts stage. * Embryo transfer on day 5 after fertilization
You may qualify if:
- Age between 20 and 35 years old.
- Body mass index between 20 - 30.
- Unexplained infertility .
- Follicle-stimulating hormone level 12 IU/L or lower (baseline level, cycle day 3).
- Normal hysteroscopy ( healthy uterus with no fibroids or other growths)
- Fresh embryo transfer of 2 or more blastocysts stage.
- Embryo transfer on day 5 after fertilization
You may not qualify if:
- Women younger than 20 years old or older than 35 years old.
- Previous one or more failed IVF.
- Uncorrected congenital or acquired uterine anomalies.
- Other causes of infertility rather than unexplained infertility.
- Less than 2 embryo transfer, cleavage stager frozen embryo transfer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University Maternity Hospital
Cairo, Abbassia, 11566, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
November 29, 2016
First Posted
December 9, 2016
Study Start
March 1, 2016
Primary Completion
March 1, 2017
Study Completion
December 1, 2017
Last Updated
December 9, 2016
Record last verified: 2016-12